4.4 Article

Highly sensitive indirect competitive enzyme-linked immunosorbent assay based on a monoclonal antibody against saikosaponin b2 for quality control of Kampo medicines containing Bupleuri radix

期刊

JOURNAL OF NATURAL MEDICINES
卷 -, 期 -, 页码 -

出版社

SPRINGER JAPAN KK
DOI: 10.1007/s11418-023-01753-3

关键词

Saikosaponin b2; Monoclonal antibody; Enzyme-linked immunosorbent assay (ELISA); Quality control; Kampo medicine

向作者/读者索取更多资源

In this study, a new icELISA method based on a highly specific anti-SSb2 monoclonal antibody was developed for the detection of SSb2 in Kampo medicines. The assay showed high specificity, accuracy, and precision, and the results were strongly correlated with those obtained using liquid chromatograph-mass spectrometer. This suggests that the developed method can be used for the quality control and standardization of Kampo medicines containing Bupleuri radix.
Saikosaponins are naturally occurring oleanane-type triterpenoids that are found in Bupleuri radix (root of Bupleurum falcatum) and exhibit a broad biological activity spectrum. Saikosaponin b2 (SSb2) is the main saikosaponin in Kampo medicine extracts and is a designated quality control marker for the same in the Japanese Pharmacopeia. Although some monoclonal antibodies (mAbs) against saikosaponins have been produced to evaluate the quality of Bupleuri radix and related products, anti-SSb2 mAbs have not been used to quantify SSb2 in Kampo medicines. To address this knowledge gap, we herein established a new hybridoma cell line secreting a highly specific anti-SSb2 mAb and developed an indirect competitive enzyme-linked immunosorbent assay (icELISA) based on this mAb for the detection of SSb2 in Bupleuri radix-containing Kampo medicines. The generated SSb2-recognized mAb exhibited high specificity to SSb2 in icELISA. The developed assay featured high sensitivity (linearity range = 1.95-125 ng/ml), accuracy, precision and reproducibility (coefficient of variation < 5%), and the thus determined SSb2 contents were strongly correlated with those obtained using liquid chromatograph-mass spectrometer. These results suggest that the anti-SSb2 mAb-based icELISA method can be used for the quality control and standardization of Kampo medicines containing Bupleuri radix.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据